Terminal-conjugated non-aggregated constraints of gold nanoparticles on lateral flow strips for mobile phone readouts of enrofloxacin.
Animals
Anti-Bacterial Agents
/ analysis
Aptamers, Nucleotide
/ chemistry
Biosensing Techniques
/ instrumentation
Cell Phone
Enrofloxacin
/ analysis
Equipment Design
Food Contamination
/ analysis
Gold
/ chemistry
Honey
/ analysis
Limit of Detection
Metal Nanoparticles
/ chemistry
Milk
/ chemistry
Models, Molecular
Paper
Reagent Strips
/ analysis
Aptamer
AuNP proximity
Enrofloxacin
Lateral flow biosensor
Terminal deoxynucleotidyl transferase
Journal
Biosensors & bioelectronics
ISSN: 1873-4235
Titre abrégé: Biosens Bioelectron
Pays: England
ID NLM: 9001289
Informations de publication
Date de publication:
15 Jul 2020
15 Jul 2020
Historique:
received:
14
02
2020
revised:
07
04
2020
accepted:
14
04
2020
pubmed:
28
4
2020
medline:
7
4
2021
entrez:
28
4
2020
Statut:
ppublish
Résumé
Antibiotics abuse now poses a global threat to public health. Monitoring their residual levels as well as metabolites are of great importance, still challenges remain in in situ tracing during the circulation. Herein, taking the typical antibacterial Enrofloxacin (ENR) as a subject, a paper-based aptasensor was tailored by manipulating a duo of aptameric moieties to "sandwich" the target in a lateral-flow regime. To visualize the tight-binding sandwich motif more vividly, an irregular yet robust DNA-bridged gold nanoparticles (AuNPs) proximity strategy was developed with recourse to terminal deoxynucleotidyl transferase, of which the nonaggregate constraining feature was unveiled via optical absorption and scanning probe topography. This complex performed exceptionally better in the test strip context than single-particle tags, leading to an enhanced on-chip focusing. Rather than qualitative color developing, further efforts were taken to visualize the readouts in a quantitative manner by exploiting the smartphone camera for pattern recognition along with data processing in a professional App. Overall, this prototyped contraption realized a rapid and ultrasensitive quantification of ENR down to 0.1 μg/L along with a broad linear range over 5 orders of magnitude, plus excellent selectivity and precision even for real samples. Such innovative fusion across DNA-structured nanomanufacturing and intelligent perception provides a prospective and invigorating solution to point-of-care inspection.
Identifiants
pubmed: 32339154
pii: S0956-5663(20)30215-3
doi: 10.1016/j.bios.2020.112218
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Aptamers, Nucleotide
0
Reagent Strips
0
Enrofloxacin
3DX3XEK1BN
Gold
7440-57-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
112218Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.